Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ECMO for Severe ARDS.

Literature DB >> 29791819

ECMO for Severe ARDS.

C Corey Hardin¹, Kathryn Hibbert¹.

Abstract

Mesh：

Year: 2018 PMID： 29791819 DOI： 10.1056/NEJMe1802676

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Half-empty or half-full?-interpretation of the EOLIA trial and thoughts for the future.

Authors: Mehul Desai; Heidi J Dalton
Journal: J Thorac Dis Date: 2018-09 Impact factor: 2.895

2. Focus on extracorporeal life support.

Authors: Peter Schellongowski; Alain Combes; Morten Hylander Møller
Journal: Intensive Care Med Date: 2018-11-21 Impact factor: 17.440

3. Characteristics and Outcomes of Severe ARDS Patients Receiving ECMO in Southern Thailand.

Authors: Nawaporn Assanangkornchai; Polathep Vichitkunakorn; Rungsun Bhurayanontachai
Journal: Clin Med Insights Circ Respir Pulm Med Date: 2019-11-01

4. Association between Cumulative Fluid Balance and Outcomes in Acute Respiratory Distress Syndrome Patients Treated with Extracorporeal Membrane Oxygenation.

Authors: Jun Hee Lee; Jong Yun Won; Ji Eon Kim; Hee Jung Kim; Jae Seung Jung; Ho Sung Son
Journal: J Chest Surg Date: 2021-02-05

5. Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS.

Authors: Lauren A Raff; Trista D Reid; Daniel Johnson; Evan J Raff; Andrew B Schneider; Anthony G Charles; Jared R Gallaher
Journal: Am J Surg Date: 2021-04-20 Impact factor: 2.565

Review 10. Evidence for lung repair and regeneration in humans: key stem cells and therapeutic functions of fibroblast growth factors.

Authors: Xuran Chu; Chengshui Chen; Chaolei Chen; Jin-San Zhang; Saverio Bellusci; Xiaokun Li
Journal: Front Med Date: 2019-11-18 Impact factor: 4.592

ECMO for Severe ARDS.

1. Half-empty or half-full?-interpretation of the EOLIA trial and thoughts for the future.

2. Focus on extracorporeal life support.

3. Characteristics and Outcomes of Severe ARDS Patients Receiving ECMO in Southern Thailand.

4. Association between Cumulative Fluid Balance and Outcomes in Acute Respiratory Distress Syndrome Patients Treated with Extracorporeal Membrane Oxygenation.

5. Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS.

6. Antiviral Abidol is Associated with the Reduction of In-Hospital Mortality in COVID-19 Patients.

7. Saving critically ill COVID-19 patients with mechanical circulatory support.

8. Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study.

Review 9. Cardiovascular involvement in COVID-19: not to be missed.

Review 10. Evidence for lung repair and regeneration in humans: key stem cells and therapeutic functions of fibroblast growth factors.